Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jay Edelberg

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial†

Journal of Clinical Lipidology

Internal Medicine

Cardiovascular Medicine

English

Endothelial Microparticles: Sophisticated Vesicles Modulating Vascular Function

Vascular Medicine

Cardiovascular Medicine

English

Related publications

The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia

Annals of Translational Medicine

English

Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India

Cardiovascular Medicine

English

High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic Dystrophy

Cardiovascular Medicine

English

Declining Rates of Fatal and Nonfatal Intracerebral Hemorrhage: Epidemiological Trends in Australia

Journal of the American Heart Association

Cardiovascular Medicine

English

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Independent of LDL Cholesterol and Statin Use: Results of the Leader Trial

Canadian Journal of Cardiology

Cardiovascular Medicine

English

Influence of Male and Female Educational Status on the Risk of Fatal Cardiovascular Events

Acta Biologica Sibirica

English

Nonfatal Outcomes in the Primary Prevention of Atherosclerotic Cardiovascular Disease: Is All-Cause Mortality Really All That Matters?

Circulation. Cardiovascular quality and outcomes

Cardiovascular Medicine

English

Lipoprotein(a) Reductions From PCSK9 Inhibition and Major Adverse Cardiovascular Events: Pooled Analysis of Alirocumab Phase 3 Trials

Atherosclerosis

Cardiovascular Medicine

English

Tobacco Smoking and Risk of 36 Cardiovascular Disease Subtypes: Fatal and Non-Fatal Outcomes in a Large Prospective Australian Study

English